The synthesis and the biological evaluation of new thiazolidin-4-one derivatives containing a xanthine moiety

Molecules

Volumn 18, Issue 8, 2013, Pages 9684-9703

  Lupascu, Florentina Geanina ^a   Dragostin, Oana Maria ^a   Foia, Liliana ^a   Lupascu, Dan ^a   Profire, Lenuta ^a  

^a GRIGORE T POPA UNIVERSITY OF MEDICINE AND PHARMACY   (Romania)

Author keywords

Antioxidant effect; Spectral methods; Synthesis; Thiazolidin 4 one; Xanthine

Indexed keywords

2-NITROBENZALDEHYDE; 4-HYDROXYBENZALDEHYDE; ANTIOXIDANT; BENZALDEHYDE DERIVATIVE; FREE RADICAL; XANTHINE; 2 NITROBENZALDEHYDE; 4 HYDROXYBENZALDEHYDE;

CHEMISTRY; INFRARED SPECTROSCOPY; METABOLISM; NUCLEAR MAGNETIC RESONANCE SPECTROSCOPY; OXIDATION REDUCTION REACTION; STRUCTURE ACTIVITY RELATION; SYNTHESIS; ARTICLE;

ANTIOXIDANTS; BENZALDEHYDES; FREE RADICALS; MAGNETIC RESONANCE SPECTROSCOPY; OXIDATION-REDUCTION; SPECTROSCOPY, FOURIER TRANSFORM INFRARED; STRUCTURE-ACTIVITY RELATIONSHIP; XANTHINE;

EID: 84883163988     PISSN: None     EISSN: 14203049     Source Type: Journal    
DOI: 10.3390/molecules18089684     Document Type: Article

References (33)

1. Lesyk, R.; Zimenkovsky, B. 4-Thiazolidones: Current status and perspectives for modern organic and medicinal chemistry. Curr. Org. Chem. 2004, 8, 1547-1578.
2. Vicini, P.; Geronikaki, A.; Anastasia, K.; Incerti, M.; Zani, F. Synthesis and antimicrobial activity of novel 2-thiazolimino-5-arylidene-4- thiazolidinones. Bioor. Med. Chem. 2006, 14, 3859-3864.
3. Alagawadi, K.R.; Alegaon, S.G. Synthesis, characterization and antimicrobial activity evaluation of new 2,4-thiazolidinediones bearing imidazo [2,1-b][1,3,4]thiadiazole moiety. Arab. J. Chem. 2011, 4, 465-472.
4. Prasad, D.; Kumar, A.; Kumar, S.P.; Nath, M. Design, synthesis and antimicrobial evaluation of novel 2-aryl-thiazolidin-4-one derivatives. Org. Med. Chem. Lett. 2011, 14, 2-7.
5. Bhagat, T.M.; Swamy, D.K.; Badne, S.G.; Kuberkar, S.V. Synthesis and antibacterial activity of 4-thiazolidinone containing benzothiazolyl moiety. Rasayan J. Chem. 2011, 4, 24-28.
6. Sharma, R.; Samadhiya, P.; Srivastava, S.; Srivastava, S. Synthesis of some new thiazolidine derivatives and their biological significance. Latv. J. Chem. 2012, 50, 296-307.
7. Amin, K.M.; Rahman, D.E.; Al-Eryani, Y.A. Synthesis and preliminary evaluation of some substituted coumarins as anticonvulsant agents. Bioorg. Med. Chem. 2008, 16, 5377-5388.
8. Parameswaran, M.; Thengungal, K.R.; Subbuchettiar, G. Synthesis of coumarin heterocyclic derivatives with antioxidant activity and in vitro cytotoxic activity against tumour cells. Acta Pharm. 2009, 59, 159-170.
9. Isloor, A.M.; Sunil, D.; Shetty, P.; Malladi, S.; Pai, K.S.R.; Maliyakki, N. Synthesis, characterization, anticancer, and antioxidant activity of some new thiazolidin-4-ones in MCF-7 cells. Med. Chem. Res. 2013, 22, 758-767.
10. Liu, Y.; Jing, F.; Xu, Y.; Xie, Y.; Shi, F.; Fangm, H.; Lim, M.; Xu, W. Design, synthesis and biological activity of thiazolidine-4-carboxylic acid derivatives as novel influenza neuraminidase inhibitors. Bioorg. Med. Chem. 2011, 19, 2342-2348.
11. Balzarini, J.; Orzeszko, B.; Maurin, J.K.; Orzeszko, A. Synthesis and anti-HIV studies of 2-adamantyl-substituted thiazolidin-4-ones. Eur. J. Med. Chem. 2007, 42, 993-1003.
12. Barros, C.D.; Amato, A.A.; de Oliveira, T.B.; Iannini, K.B.; Silva, A.L.; Silva, T.G., Leitem, E.S.; Hernandes, M.Z.; de Lima, M.C.A.; Galdino, S.L.; et al. Synthesis and anti-inflammatory activity of new arylidene-thiazolidine-2,4- diones as PPARgamma ligands. Bioorg. Med. Chem. 2010, 18, 3805-3811.
13. Vazzana, I.; Terranova, E.; Mattioli, F.; Sparatore, F. Aromatic schiff bases and 2,3-disubstituted-1,3-thiazolidin-4-one derivatives as antiinflammatory agents. ARKIVOC 2004, v, 364-374.
14. Kim, H.; Haluzik, M.; Gavrilova, O.; Yakar, S.; Portas, J.; Sun, H.; Pajvani, U.B.; Scherer, P.E.; LeRoith, D. Thiazolidinediones improve insulin sensitivity in adipose tissue and reduce the hyperlipidemia without affecting the hyperglycaemia in a transgenic model of type 2 diabetes. Diabetologia 2004, 47, 2215-2225.
15. Iqbal, A.K.M.; Khan, A.Y.; Kalashetti, M.B.; Belavagi, N.S.; Gong, Y.D.; Khazi, I.A. Synthesis, hypoglycemic and hypolipidemic activities of novel thiazolidinedione derivatives containing thiazole/triazole/oxadiazole ring. Eur. J. Med. Chem. 2012, 53, 308-315.
16. Da Costa Leite, L.F.; Veras Mourão, R.H.; de Lima Mdo, C.; Galdino, S.L.; Hernandes, M.Z.; de Assis Rocha Neves, F.; Vidal, S.; Barbe, J.; da Rocha Pitta, I. Synthesis, biological evaluation and molecular modeling studies of arylidene-thiazolidinediones with potential hypoglycemic and hypolipidemic activities. Eur. J. Med. Chem. 2007, 42, 1263-1271.
17. Kishore, A.; Nampurath, G.K.; Mathew, S.P.; Zachariah, R.T.; Potu, B.K.; Rao, M.S.; Valiathan, M.; Chamallamudi, M.R. Antidiabetic effect through islet cell protection in streptozotocin diabetes: A preliminary assessment of two thiazolidin-4-ones in Swiss albino mice. Chem. Biol. Interact. 2009, 177, 242-266.
18. Derosa, G.; Maffioli, P. Effects of thiazolidinediones and sulfonylureas in patients with diabetes. Diabetes Technol. Ther. 2010, 12, 491-501.
19. Alberti, K.G.; Zimmet, P.; Shaw, J. Metabolic syndrome - A new world-wide definition. A consensus statement from the international diabetes federation. Diabet. Med. 2006, 23, 469-480.
20. Hughes, T.E. Emerging therapies for metabolic diseases - The focus is on diabetes and obesity. Curr. Opin. Chem. Biol. 2009, 13, 1-6.
21. Kushwaha, S.P.; Rawat, S.K.; Abhishekm, P.K.; Tripathim K. Coupling antioxidant and antidiabetic assests of 2,4-thiazolidinedione derivatives. Asian J. Pharm. 2011, 1, 71-73.
22. El Nezhawy, A.O.H.; Ramla, M.M.; Khalifa, N.M.; Abdulla, M.M. Synthesis and antioxidant activity of some thiazolidin-4-one derivatives. Monatsh. Chem. 2009, 140, 531-539.
23. Lupaşcu, F.; Dragostin O.M.; Apotrosoaei M.; Pânzariu, A.; Lupaşcu, D.; Vasile, C.; Profire, L. Synthesis and evaluation of antioxidant activity of some new benzylidene-thiazolidine-xanthine derivatives. Rev. Med. Chir. 2013, 117, 244-249.
24. Kusano, C.; Ferrari, B. Total Antioxidant Capacity: A biomarker in biomedical and nutritional studies. J. Cell Mol. Biol. 2008, 7, 1-15.
25. Schwartz, S.L. Treatment of Elderly Patients With Type 2 Diabetes mellitus: A systematic review of the benefits and risks of dipeptidyl peptidase-4 inhibitors. Am. J. Geriatr. Pharmacother. 2010, 5, 405-418.
26. Baetta, R.; Corsini, A. Pharmacology of dipeptidyl peptidase-4 inhibitors: Similarities and differences. Drugs 2011, 71, 1441-1467.
27. Bhat, V.B.; Madyastha, K.M. Antioxidant and radical scavenging properties of 8-oxo derivatives of xanthine drugs pentoxifylline and lisofylline. Biochem. Biophys. Res. Commun. 2001, 288, 1212-1217.
28. Kaptanoglu, E.; Solaroglu, I.; Akbiyik, F.; Demirpence, E.; Ergungor, M.E. The antioxidant effect of aminophylline in rat brain and spinal cord homogenates. Turk. Neurosurg. 2003, 13, 9-13.
29. Lupascu, F.; Dash, M.; Samal, S.K; Lupusoru, C.E.; Lupusoru, P.; Profire, L.; Dubruel, P. Delivery of hydrophobic antioxidant drugs via chitosan: An approach to enhance their oral bioavailability. J. Mater. Sci. Mater. Med. 2013, submitted.
30. Lungu Apetrei, C.; Tuchilus, C.; Aprotosoaie, A.C. Chemical, antioxidant and antimicrobial investigations of pinus cembra L. bark and needles. Molecules 2011, 16, 7773-7788.
31. Cacic, M.; Molnar, M.; Sarkanj, B.; Has-Schon, E.; Rajkovic, V. Synthesis and antioxidant activity of some new coumarinyl-1,3-Thiazolidine-4-ones. Molecules 2010, 15, 6795-6809.
32. Shih, M-H.; Ke, F.-Y. Syntheses and evaluation of antioxidant activity of sydnonyl substituted thiazolidinone and thiazoline derivatives. Bioorg. Med. Chem. 2004, 12, 4633-4643.
33. Re, R.; Pellegrini, N.; Proteggente, A.; Pannala, A.; Yang, M.; Rice-Evans, C. Antioxidant activity applying an improved ABTS radical cation decolorization assay. Free Radic. Biol. Med. 1999, 26, 1231-1237.